Year |
Citation |
Score |
2010 |
Glantz LA, Gilmore JH, Overstreet DH, Salimi K, Lieberman JA, Jarskog LF. Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression. Schizophrenia Research. 118: 292-9. PMID 20067857 DOI: 10.1016/J.Schres.2009.12.027 |
0.536 |
|
2007 |
Glantz LA, Gilmore JH, Hamer RM, Lieberman JA, Jarskog LF. Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood Neuroscience. 149: 582-591. PMID 17916412 DOI: 10.1016/J.Neuroscience.2007.06.036 |
0.358 |
|
2007 |
Jarskog LF, Gilmore JH, Glantz LA, Gable KL, German TT, Tong RI, Lieberman JA. Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 95-102. PMID 16641945 DOI: 10.1038/Sj.Npp.1301074 |
0.427 |
|
2006 |
Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophrenia Research. 81: 47-63. PMID 16226876 DOI: 10.1016/J.Schres.2005.08.014 |
0.548 |
|
2005 |
Jarskog LF, Glantz LA, Gilmore JH, Lieberman JA. Apoptotic mechanisms in the pathophysiology of schizophrenia Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29: 846-858. PMID 15908096 DOI: 10.1016/J.Pnpbp.2005.03.010 |
0.546 |
|
2003 |
Lewis DA, Glantz LA, Pierri JN, Sweet RA. Altered Cortical Glutamate Neurotransmission in Schizophrenia: Evidence from Morphological Studies of Pyramidal Neurons Annals of the New York Academy of Sciences. 1003: 102-112. PMID 14684438 DOI: 10.1196/Annals.1300.007 |
0.653 |
|
2003 |
Glantz L, Gilmore J, Lieberman J, Jarskog L. Decreased PAR-4 in the temporal cortex of subjects with schizophrenia Schizophrenia Research. 60: 62. DOI: 10.1016/S0920-9964(03)80569-8 |
0.664 |
|
2001 |
Glantz LA, Lewis DA. Dendritic spine density in schizophrenia and depression. Archives of General Psychiatry. 58: 203. PMID 11177126 DOI: 10.1001/Archpsyc.58.2.203 |
0.551 |
|
2000 |
Glantz LA, Austin MC, Lewis DA. Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia. Biological Psychiatry. 48: 389-97. PMID 10978722 DOI: 10.1016/S0006-3223(00)00923-9 |
0.665 |
|
2000 |
Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Archives of General Psychiatry. 57: 65-73. PMID 10632234 DOI: 10.1001/Archpsyc.57.1.65 |
0.686 |
|
1998 |
Gullion K, Glantz L, Lewis D. 384. Are PFC pyramidal neurons in the thalamic recipient zone altered in schizophrenia? Biological Psychiatry. 43: S115-S116. DOI: 10.1016/S0006-3223(98)90832-0 |
0.608 |
|
1997 |
Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Archives of General Psychiatry. 54: 943-52. PMID 9337775 DOI: 10.1001/Archpsyc.1997.01830220065010 |
0.687 |
|
1997 |
Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Archives of General Psychiatry. 54: 660-9. PMID 9236550 DOI: 10.1001/archpsyc.1997.01830190088009 |
0.707 |
|
1997 |
Lewis DA, Glantz LA. Specificity of decreased spine density on layer III pyramidal cells in schizophrenia Schizophrenia Research. 24: 39. DOI: 10.1016/S0920-9964(97)82110-X |
0.577 |
|
1995 |
Lewis D, Glantz L. Selective decrease of synaptophysin immunoreactivity in the prefrontal cortex of schizophrenic subjects Schizophrenia Research. 15: 64. DOI: 10.1016/0920-9964(95)95202-K |
0.511 |
|
1994 |
Glantz L, Lewis D. Decreased synaptophysin immunoreactivity in prefrontal cortex of schizophrenics Biological Psychiatry. 35: 717. DOI: 10.1016/0006-3223(94)91024-3 |
0.525 |
|
Low-probability matches (unlikely to be authored by this person) |
2008 |
Salimi K, Glantz LA, Hamer RM, German TT, Gilmore JH, Jarskog LF. Regulation of complexin 1 and complexin 2 in the developing human prefrontal cortex. Synapse (New York, N.Y.). 62: 273-82. PMID 18240322 DOI: 10.1002/Syn.20492 |
0.264 |
|
2019 |
Cruz DA, Glantz LA, McGaughey KD, Parke G, Shampine LJ, Kilts JD, Naylor JC, Marx CE, Williamson DE. Neurosteroid Levels in the Orbital Frontal Cortex of Subjects with PTSD and Controls: A Preliminary Report. Chronic Stress (Thousand Oaks, Calif.). 3. PMID 31276078 DOI: 10.1177/2470547019838570 |
0.183 |
|
Hide low-probability matches. |